Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgaf392 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Andrea K Steck und 10 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Genetic Predisposition to Disease, Prediabetic State. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institute of Allergy and Infectious Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
The influence of genetic factors on the transition through preclinical stages of type 1 diabetes (T1D) has not been studied.
Objective
Our aim was to evaluate the influence of genetic factors on transition through T1D stages.
Methods
In TrialNet participants who have been genotyped with the TEDDY-T1DExomeChip array (Illumina HumanCoreExome Beadarray with custom content), we evaluated the influence of the overall T1D genetic risk score (GRS2), its human leukocyte antigen (HLA) and non-HLA components, HLA-DR3 and HLA-DR4 haplotypes, and 90 single-nucleotide variations previously associated with islet autoimmunity and/or T1D on 3 transitions between diabetes stages: from single confirmed autoantibody positive to stage 1 (N = 4314), from stage 1 to stage 2 (N = 3066), and from stage 2 to stage 3 (clinical) T1D (N = 2045).
Results
The T1D GRS2 was associated with all 3 transitions with hazard ratios (HRs) of 1.11 (1.09-1.14) for single-autoantibody positivity to stage 1, HR 1.05 (1.03-1.08) for stage 1 to 2, and HR 1.13 (1.09-1.17) for stage 2 to 3 T1D. The T1D GRS2 HLA and HLA class II components were associated with all 3 transitions. The HLA class I component and the HLA-DR4 haplotype were associated with the transition from single-autoantibody positivity to stage 1 and from stage 2 to stage 3 T1D, while HLA-DR3 was associated only with the latter.
Conclusion
Genetics influence transitions through each stage of preclinical T1D, with main contributions from HLA class II. These results increase our understanding of T1D development and support incorporating the T1D GRS2 to enhance the prediction of progression through the preclinical stages of T1D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
- Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
- Department of Genetic Medicine and Development, University of Geneva, Geneva 1211, Switzerland.
- Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK.
- Department of Genome Sciences, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Pediatrics, Division of Diabetes and Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.
ORCID-Profile: Andrea K Steck, Hemang M Parikh, Taylor M Triolo, Richard A Oram, Jeffrey P Krischer
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Steck, A. K., Parikh, H. M., Triolo, T. M., Ferrat, L., You, L., Gottlieb, P. A., Oram, R. A., Onengut-Gumuscu, S., Krischer, J. P., Rich, S. S., & Redondo, M. J. (2026). Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf392
Vancouver
Steck AK, Parikh HM, Triolo TM, Ferrat L, You L, Gottlieb PA, et al. Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf392
BibTeX
@article{Steck2026,
author = {Steck, Andrea K and Parikh, Hemang M and Triolo, Taylor M and Ferrat, Lauric and You, Lu and Gottlieb, Peter A and Oram, Richard A and Onengut-Gumuscu, Suna and Krischer, Jeffrey P and Rich, Stephen S and Redondo, Maria J},
title = {Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgaf392}
}
EUVIMED